Institutional News

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Dr. Juan Manuel Pérez - 31 March, 2026 0

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Dr. Juan Manuel Pérez - 31 March, 2026 0

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Dr. Juan Manuel Pérez - 31 March, 2026 0

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy

THO / Medscape

Mobile app -New version-

SOLACI presents the Brazilian Magazine of Interventional Cardiology

Letter from the President 2013-2015

Cooperation Agreement SOLACI-CRF/TCT

Last News

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Institutional News

Panama Sessions 2026 – Young Interventional Cardiologists Contest. Submit Your Case

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

Access